- Home
- PODD vs CBOE Comparison
PODD vs CBOE Comparison
Compare PODD & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- CBOE
- Stock Information
- Founded
- PODD 2000
- CBOE 1973
- Country
- PODD United States
- CBOE United States
- Employees
- PODD N/A
- CBOE 1685
- Industry
- PODD Medical/Dental Instruments
- CBOE Investment Bankers/Brokers/Service
- Sector
- PODD Health Care
- CBOE Finance
- Exchange
- PODD Nasdaq
- CBOE Nasdaq
- Market Cap
- PODD 21.5B
- CBOE 23.7B
- IPO Year
- PODD 2007
- CBOE 2010
- Fundamental
- Price
- PODD $302.52
- CBOE $226.33
- Analyst Decision
- PODD Strong Buy
- CBOE Hold
- Analyst Count
- PODD 19
- CBOE 13
- Target Price
- PODD $320.11
- CBOE $223.31
- AVG Volume (30 Days)
- PODD 796.4K
- CBOE 702.1K
- Earning Date
- PODD 08-07-2025
- CBOE 08-01-2025
- Dividend Yield
- PODD N/A
- CBOE 1.11%
- EPS Growth
- PODD 67.46
- CBOE 2.12
- EPS
- PODD 5.55
- CBOE 7.62
- Revenue
- PODD $2,198,900,000.00
- CBOE $4,332,300,000.00
- Revenue This Year
- PODD $24.49
- CBOE N/A
- Revenue Next Year
- PODD $17.45
- CBOE $4.18
- P/E Ratio
- PODD $54.39
- CBOE $29.88
- Revenue Growth
- PODD 23.48
- CBOE 15.76
- 52 Week Low
- PODD $173.00
- CBOE $166.88
- 52 Week High
- PODD $329.33
- CBOE $236.02
- Technical
- Relative Strength Index (RSI)
- PODD 47.95
- CBOE 58.40
- Support Level
- PODD $299.47
- CBOE $223.61
- Resistance Level
- PODD $310.18
- CBOE $229.00
- Average True Range (ATR)
- PODD 6.66
- CBOE 3.61
- MACD
- PODD -3.22
- CBOE 0.21
- Stochastic Oscillator
- PODD 25.46
- CBOE 85.76
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
About CBOE Cboe Global Markets Inc.
Cboe Global Markets Inc is a provider of market infrastructure and tradable products, that delivers cutting-edge trading, clearing, and investment solutions to market participants around the world. The Company is committed to operating a trusted, inclusive all over world marketplace, and to providing products, technology, and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX, and digital assets, across North America, Europe, and Asia Pacific.